Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-06-08

Clinical Trial Update: Prevention of Contrast Induced Nephropathy (NIC) by Intravenous Versus Oral Rehydration [NA]

View source ↗

Summary

A completed clinical trial comparing intravenous versus oral rehydration for prevention of contrast-induced nephropathy in patients with acute kidney injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Clinica Universidad de Navarra, Universidad de Navarra | Conditions: KIDNEY FAILURE, ACUTE | NA | Status: COMPLETED